Developer docs
API playgroundTry for free, no card

Search company profiles

RTsafe

Full company profile

uuid0003p1q

Namestring
RTsafe
Websiteurl
rt-safe.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

RTsafe is a privately held medical device company founded in 2014 and headquartered in Athens, Greece. According to its firmographic profile, the company developed, patented, and commercialized what it describes as the world's first FDA-cleared Personalized Care service in Radiation Oncology. Its offering targets the patient-specific quality assurance and dosimetry verification problem in radiotherapy — a clinically critical workflow at cancer treatment centers where personalized pre-treatment plan validation reduces misadministration risk. The company has 11–50 employees and operates within the image-guided radiation therapy market, which industry commentary projects will reach $2.48 billion by 2030 at a 4.4% CAGR, driven by AI integration, demand for non-invasive cancer therapies, and emerging-market accessibility.

The business model centers on selling or licensing patient-specific QA solutions to radiotherapy centers and cancer treatment providers, monetizing FDA-cleared clinical software/phantoms in a niche but high-safety-stakes segment of radiation oncology. Capital has been sourced primarily from Greek and European seed-stage backers: VentureFriends led two rounds (2017: $2.25M; 2019: $1.0M), with earlier support from The Hellenic Initiative ($250K, 2014), Envolve Entrepreneurship (incubator, 2014), MIT Enterprise Forum Greece ($10K, 2015), and undisclosed seed investors ($400K, 2016; $35K, 2015). Founder Evangelos Pappas serves as CEO; co-founder Nikos Stergiopoulos and Chief MR Technology Officer Thomas Maris round out the executive team, with the CTO role signaling MR-guided radiotherapy as a focus area.

The current operating state is materially uncertain. The firm's public website (rt-safe.com) currently displays only a "loading/verification" page with no accessible content. The last disclosed financing is March 2019, and the available sources contain no customer logos, pricing, partnership announcements, product roadmap updates, or revenue data. Whether the company remains commercially active, has pivoted, or is effectively dormant cannot be confirmed from the input data — a fact that materially constrains any forward-looking inference about the business.

Short descriptiontext

RTsafe is an Athens, Greece-based medical device company that developed and patented an FDA-cleared personalized quality assurance service for radiation oncology, serving radiotherapy centers and cancer treatment providers.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAthens, Greece
HQ citystring
Athens
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
patient-specific QA, radiation oncology, dosimetry verification, 3D-printed phantoms, radiotherapy quality assurance
Industry3 codes
PRIMARYHLAKAFAC
Radiation Oncology
SECONDARYHLAHABAH
Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAH
Radiation Dose Management & Analytics
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code2 codes
  • Irradiation Apparatus Manufacturing334517
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Health Services8000
Product category
Radiation Oncology Quality Assurance
Social media profiles1 record
Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

RTsafe developed, patented, and commercialized the world's first FDA-cleared Personalized Care service in Radiation Oncology. The offering centers on patient-specific (3D-printed) dosimetry phantoms and associated QA workflows that allow radiotherapy centers to verify treatment plan delivery on an anatomic replica of the individual patient prior to treatment.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Personalized Care Service (Patient-Specific QA)
CategoryPatient-Specific Quality Assurance
2Patient-Specific 3D-Printed Phantoms
CategoryMedical Dosimetry Devices
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sun Nuclear is a leading provider of patient-specific QA phantoms, dosimetry, and quality assurance solutions for radiation oncology, directly overlapping with RTsafe's personalized QA service.

TypeDirect peer
Description

Standard Imaging manufactures QA phantoms, electrometers, and dosimetry tools used in radiation therapy treatment verification, making it one of the closest comparables to RTsafe's patient-specific phantom offering.

TypeDirect peer
Description

IBA Dosimetry provides patient-specific QA solutions, dosimetry equipment, and software for radiation therapy, directly competing with RTsafe in the personalized QA workflow.

4CIRS (Computerized Imaging Reference Systems)
TypeDirect peer
Description

CIRS designs tissue-equivalent phantoms and simulation models used in radiation therapy QA and imaging, overlapping with RTsafe's patient-specific phantom technology.

TypeDirect peer
Description

Modus Medical makes QA phantoms, software, and dosimetry tools for radiation treatment verification, competing head-to-head with RTsafe in patient-specific QA.

TypeBroad incumbent
Description

Varian is a dominant radiation oncology OEM with an installed base of linacs and integrated QA/treatment planning software; it competes with RTsafe by offering bundled QA capabilities alongside its core equipment.

TypeBroad incumbent
Description

Elekta is a major radiation therapy and radiosurgery OEM whose treatment planning and QA ecosystem overlaps with the workflow RTsafe enables.

TypeBroad incumbent
Description

Accuray develops CyberKnife and TomoTherapy systems with integrated QA and treatment planning, representing the broad-incumbent OEM approach that RTsafe's QA layer complements or competes with.

TypeEmerging player
Description

ViewRay pioneered MR-guided radiation therapy systems; its MR-linac workflow intersects with RTsafe's MR-focused personalized QA positioning.

TypeDirect peer
Description

PTW is a global provider of dosimetry and QA solutions for radiation therapy, including detectors and phantoms used in patient-specific treatment verification, directly comparable to RTsafe.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RTsafe

Radiation Oncology Quality Assurancert-safe.com

RTsafe is an Athens, Greece-based medical device company that developed and patented an FDA-cleared personalized quality assurance service for radiation oncology, serving radiotherapy centers and cancer treatment providers.

What RTsafe does

RTsafe is a privately held medical device company founded in 2014 and headquartered in Athens, Greece. According to its firmographic profile, the company developed, patented, and commercialized what it describes as the world's first FDA-cleared Personalized Care service in Radiation Oncology. Its offering targets the patient-specific quality assurance and dosimetry verification problem in radiotherapy — a clinically critical workflow at cancer treatment centers where personalized pre-treatment plan validation reduces misadministration risk. The company has 11–50 employees and operates within the image-guided radiation therapy market, which industry commentary projects will reach $2.48 billion by 2030 at a 4.4% CAGR, driven by AI integration, demand for non-invasive cancer therapies, and emerging-market accessibility.

The business model centers on selling or licensing patient-specific QA solutions to radiotherapy centers and cancer treatment providers, monetizing FDA-cleared clinical software/phantoms in a niche but high-safety-stakes segment of radiation oncology. Capital has been sourced primarily from Greek and European seed-stage backers: VentureFriends led two rounds (2017: $2.25M; 2019: $1.0M), with earlier support from The Hellenic Initiative ($250K, 2014), Envolve Entrepreneurship (incubator, 2014), MIT Enterprise Forum Greece ($10K, 2015), and undisclosed seed investors ($400K, 2016; $35K, 2015). Founder Evangelos Pappas serves as CEO; co-founder Nikos Stergiopoulos and Chief MR Technology Officer Thomas Maris round out the executive team, with the CTO role signaling MR-guided radiotherapy as a focus area.

The current operating state is materially uncertain. The firm's public website (rt-safe.com) currently displays only a "loading/verification" page with no accessible content. The last disclosed financing is March 2019, and the available sources contain no customer logos, pricing, partnership announcements, product roadmap updates, or revenue data. Whether the company remains commercially active, has pivoted, or is effectively dormant cannot be confirmed from the input data — a fact that materially constrains any forward-looking inference about the business.

RTsafe firmographics

Firmographics
Name
RTsafe
Website
https://rt-safe.com
Company type
Private
Founded year
2014
Headcount range
11–50 employees
Short description
RTsafe is an Athens, Greece-based medical device company that developed and patented an FDA-cleared personalized quality assurance service for radiation oncology, serving radiotherapy centers and cancer treatment providers.
Ownership category
akta.pro rank

RTsafe industry classification

Industry
Product category
Radiation Oncology Quality Assurance
NAICS
Irradiation Apparatus Manufacturing (334517), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAKAFAC
Radiation Oncology
SECONDARYHLAHABAH
Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAH
Radiation Dose Management & Analytics
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Patient-specific QA
  • Radiation oncology
  • Dosimetry verification
  • 3D-printed phantoms
  • Radiotherapy quality assurance

Where RTsafe is headquartered

Location

Headquarters

HQ city
Athens
HQ country
Greece
HQ region
Europe

Markets served

RTsafe business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

RTsafe product offering

Product offering

Core offering

RTsafe developed, patented, and commercialized the world's first FDA-cleared Personalized Care service in Radiation Oncology. The offering centers on patient-specific (3D-printed) dosimetry phantoms and associated QA workflows that allow radiotherapy centers to verify treatment plan delivery on an anatomic replica of the individual patient prior to treatment.

Differentiator

Problem solved

Functional benefit

Products and services

  • Personalized Care Service (Patient-Specific QA)
  • Patient-Specific 3D-Printed Phantoms

Companies that use RTsafe

Customer profile

Ideal customer profiles1 record

RTsafe technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

RTsafe partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

RTsafe competitors and assessment

Company assessment

Direct peers

  • Sun Nuclear (Mirion Technologies): Sun Nuclear is a leading provider of patient-specific QA phantoms, dosimetry, and quality assurance solutions for radiation oncology, directly overlapping with RTsafe's personalized QA service.
  • Standard Imaging: Standard Imaging manufactures QA phantoms, electrometers, and dosimetry tools used in radiation therapy treatment verification, making it one of the closest comparables to RTsafe's patient-specific phantom offering.
  • IBA Dosimetry: IBA Dosimetry provides patient-specific QA solutions, dosimetry equipment, and software for radiation therapy, directly competing with RTsafe in the personalized QA workflow.
  • CIRS (Computerized Imaging Reference Systems): CIRS designs tissue-equivalent phantoms and simulation models used in radiation therapy QA and imaging, overlapping with RTsafe's patient-specific phantom technology.
  • Modus Medical Devices: Modus Medical makes QA phantoms, software, and dosimetry tools for radiation treatment verification, competing head-to-head with RTsafe in patient-specific QA.
  • PTW (Physikalisch-Technische Werkstätten): PTW is a global provider of dosimetry and QA solutions for radiation therapy, including detectors and phantoms used in patient-specific treatment verification, directly comparable to RTsafe.

Broad incumbents

  • Varian Medical Systems (Siemens Healthineers): Varian is a dominant radiation oncology OEM with an installed base of linacs and integrated QA/treatment planning software; it competes with RTsafe by offering bundled QA capabilities alongside its core equipment.
  • Elekta: Elekta is a major radiation therapy and radiosurgery OEM whose treatment planning and QA ecosystem overlaps with the workflow RTsafe enables.
  • Accuray: Accuray develops CyberKnife and TomoTherapy systems with integrated QA and treatment planning, representing the broad-incumbent OEM approach that RTsafe's QA layer complements or competes with.

Emerging players

  • ViewRay: ViewRay pioneered MR-guided radiation therapy systems; its MR-linac workflow intersects with RTsafe's MR-focused personalized QA positioning.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

RTsafe social profiles

Digital presence

RTsafe financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RTsafe leadership team

Management profile

Number of profiles

Profiles3 records

RTsafe funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RTsafe M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RTsafe

What does RTsafe do?

RTsafe developed, patented, and commercialized the world's first FDA-cleared Personalized Care service in Radiation Oncology. The offering centers on patient-specific (3D-printed) dosimetry phantoms and associated QA workflows that allow radiotherapy centers to verify treatment plan delivery on an anatomic replica of the individual patient prior to treatment.

When was RTsafe founded?

RTsafe was founded in 2014. It employs 11 to 50 people.

Where is RTsafe based?

RTsafe is headquartered in Athens, Greece, in the Europe region.

Who are RTsafe's main competitors?

Direct peers on record are Sun Nuclear (Mirion Technologies), Standard Imaging, IBA Dosimetry, CIRS (Computerized Imaging Reference Systems), Modus Medical Devices and PTW (Physikalisch-Technische Werkstätten). Broad incumbents are Varian Medical Systems (Siemens Healthineers), Elekta and Accuray. ViewRay is listed as an emerging player.

Does RTsafe have an API?

No public API is recorded for RTsafe.

What industry is RTsafe in?

RTsafe's product category is Radiation Oncology Quality Assurance. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim). Its NAICS code is 334517 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals